Bridgewater Associates’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Sell |
11,184
-6,182
| -36% | -$1.67M | 0.01% | 556 |
|
|
2025
Q4 | $4.36M | Buy |
17,366
+6,973
| +67% | +$1.85M | 0.02% | 573 |
|
|
2025
Q3 | $2.98M | Buy |
10,393
+7,622
| +275% | +$2.04M | 0.01% | 622 |
|
|
2025
Q2 | $727K | Sell |
2,771
-15,280
| -85% | -$3.72M | ﹤0.01% | 495 |
|
|
2025
Q1 | $4.2M | Sell |
18,051
-18,401
| -50% | -$4.47M | 0.02% | 386 |
|
|
2024
Q4 | $8.36M | Sell |
36,452
-113,426
| -76% | -$26M | 0.04% | 279 |
|
|
2024
Q3 | $33.5M | Sell |
149,878
-57,632
| -28% | -$12.7M | 0.19% | 102 |
|
|
2024
Q2 | $42.2M | Buy |
207,510
+42,160
| +25% | +$8.58M | 0.22% | 73 |
|
|
2024
Q1 | $36.1M | Buy |
165,350
+87,733
| +113% | +$19.3M | 0.18% | 98 |
|
|
2023
Q4 | $17.6M | Sell |
77,617
-62,411
| -45% | -$13.1M | 0.1% | 160 |
|
|
2023
Q3 | $28.2M | Sell |
140,028
-23,772
| -15% | -$5.01M | 0.17% | 101 |
|
|
2023
Q2 | $34M | Buy |
163,800
+5,580
| +4% | +$1.08M | 0.21% | 91 |
|
|
2023
Q1 | $31.2M | Sell |
158,220
-5,061
| -3% | -$1.04M | 0.19% | 99 |
|
|
2022
Q4 | $33M | Sell |
163,281
-35,247
| -18% | -$6.89M | 0.18% | 108 |
|
|
2022
Q3 | $34.9M | Sell |
198,528
-5,664
| -3% | -$1.16M | 0.18% | 108 |
|
|
2022
Q2 | $41.1M | Buy |
204,192
+17,834
| +10% | +$3.8M | 0.17% | 116 |
|
|
2022
Q1 | $42.2M | Buy |
186,358
+48,977
| +36% | +$11.5M | 0.17% | 105 |
|
|
2021
Q4 | $37.1M | Buy |
137,381
+22,009
| +19% | +$5.45M | 0.22% | 86 |
|
|
2021
Q3 | $27.9M | Buy |
115,372
+18,608
| +19% | +$4.69M | 0.15% | 110 |
|
|
2021
Q2 | $22.9M | Buy |
96,764
+42,852
| +79% | +$9.76M | 0.15% | 118 |
|
|
2021
Q1 | $11.8M | Sell |
53,912
-3,325
| -6% | -$667K | 0.1% | 146 |
|
|
2020
Q4 | $10M | Buy |
57,237
+30,204
| +112% | +$5.22M | 0.09% | 121 |
|
|
2020
Q3 | $4.37M | Buy |
27,033
+22,888
| +552% | +$3.63M | 0.05% | 155 |
|
|
2020
Q2 | $592K | Sell |
4,145
-2,088
| -33% | -$289K | 0.01% | 238 |
|
|
2020
Q1 | $677K | Buy |
+6,233
| New | +$898K | 0.01% | 250 |
|
|
2019
Q2 | – | Sell |
-25,102
| Closed | -$3.3M | – | 344 |
|
|
2019
Q1 | $3.3M | Sell |
25,102
-171,641
| -87% | -$21.1M | 0.02% | 170 |
|
|
2018
Q4 | $21.4M | Buy |
+196,743
| New | +$26.4M | 0.2% | 68 |
|
|
2017
Q4 | – | Sell |
-49,659
| Closed | -$6.44M | – | 294 |
|
|
2017
Q3 | $6.44M | Buy |
+49,659
| New | +$6.62M | 0.04% | 97 |
|
|
2017
Q1 | – | Sell |
-12,106
| Closed | -$1.33M | – | 283 |
|
|
2016
Q4 | $1.33M | Sell |
12,106
-23,796
| -66% | -$2.64M | 0.01% | 216 |
|
|
2016
Q3 | $4.24M | Buy |
35,902
+13,189
| +58% | +$1.55M | 0.04% | 135 |
|
|
2016
Q2 | $2.54M | Sell |
22,713
-10,112
| -31% | -$1.09M | 0.03% | 176 |
|
|
2016
Q1 | $3.3M | Buy |
32,825
+11,843
| +56% | +$1.14M | 0.04% | 162 |
|
|
2015
Q4 | $2.23M | Sell |
20,982
-44,215
| -68% | -$4.56M | 0.03% | 174 |
|
|
2015
Q3 | $6.08M | Buy |
65,197
+18,647
| +40% | +$1.93M | 0.08% | 120 |
|
|
2015
Q2 | $4.85M | Sell |
46,550
-65,818
| -59% | -$6.85M | 0.04% | 108 |
|
|
2015
Q1 | $12.2M | Buy |
112,368
+30,846
| +38% | +$3.17M | 0.09% | 47 |
|
|
2014
Q4 | $7.56M | Buy |
81,522
+18,042
| +28% | +$1.59M | 0.06% | 74 |
|
|
2014
Q3 | $5.55M | Buy |
63,480
+26,854
| +73% | +$2.43M | 0.04% | 91 |
|
|
2014
Q2 | $3.22M | Buy |
36,626
+27,277
| +292% | +$2.36M | 0.02% | 141 |
|
|
2014
Q1 | $789K | Buy |
+9,349
| New | +$746K | 0.01% | 254 |
|
|
2013
Q4 | – | Sell |
-41,691
| Closed | -$3.55M | – | 330 |
|
|
2013
Q3 | $3.55M | Buy |
41,691
+9,215
| +28% | +$776K | 0.03% | 123 |
|
|
2013
Q2 | $2.79M | Buy |
+32,476
| New | +$2.7M | 0.02% | 133 |
|
Other funds holding LH
VCM
VPM
Bridgewater Associates's LH Position: Q1 2026 in Review
Bridgewater Associates reduced its Labcorp (LH) stake by 36% in Q1 2026, selling an estimated $1.67M and leaving 11,184 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #556.
Bridgewater Associates first reported a position in LH in Q2 2013 and has held it in 42 quarters since. The position peaked at $42.2M in Q2 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Bridgewater Associates held 11,184 shares of Labcorp worth $2.98M as of Q1 2026.
- Bridgewater Associates sold 6,182 Labcorp shares in Q1 2026, an estimated $1.67M.
- Labcorp made up 0.01% of Bridgewater Associates's portfolio in Q1 2026, its #556 holding.
- Bridgewater Associates first reported a position in Labcorp in Q2 2013 and has held it in 42 quarters since.
- Bridgewater Associates's Labcorp position peaked at $42.2M in Q2 2024.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.